177Lu-PSMA-617
novartis
['crpc']
treatment with 177lu-psma-617 provided consistent benefit in patients with psma-positive
mcrpc, regardless of prior treatment or
concomitant soc chosen
#asco22 
Medical oncologist. Lung and genitourinary cancer.
#lcsm #pcsm #kcsm